Search


Search Parameters








1 - 17 of 17 items
Four words regarding clinical trials: science/profit, risks/benefits Open Access
Antonio Ugalde, Núria Homedes

Globalization and medical identities in clinical trials Open Access
Medardo Ávila Vázquez

The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America Open Access
Antonio Ugalde, Núria Homedes

The use of placebos in phase III clinical trials in Brazil Open Access
Gustavo Butzge Rubenich, Stephanie Tomasi Heck, Fernando Hellmann, Bruno Rodolfo Schlemper Junior

Universal ethical principles and their application in clinical drug trials Open Access
Eduardo Sergio Gonorazky

Clinical trials, the State and society: where does science end and profit-making begin? Open Access
Cláudio Lorenzo, Volnei Garrafa

Two more words regarding clinical trials: deception/truth, the moral anemia of Big Pharma Open Access
Marvin Gómez-Vargas

Questioning clinical trials Open Access
Ricardo Alberto Martínez

Toward independent clinical trials in Latin America. Comments on "Four words regarding clinical trials" Open Access
Carlos Daniel Tajer

Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects Open Access
Núria Homedes, Antonio Ugalde

The precautionary principle in biomedical research, safety, post-research obligations and alleged therapeutic efficacy of experimental drugs: Violations of patient dignity Open Access
Sergio Eduardo Gonorazky

Clinical research in Latin America and Argentina: time for a change? Open Access
Daniel Ferrante

Four other keywords to critically analyze a clinical trial: hypothesis, implementation, analysis and publication Open Access
Teresa Forcades i Vila

Authors' response Open Access
Ugalde Antonio, Núria Homedes

Antipsychotics for schizophrenia: the paradigm of psychiatric drugs Open Access
Emilio Pol Yanguas

Medicamentos
Therapeutic value and price of the new pharmaceuticals commercialized in Argentina: Are they worth what they cost? Open Access
Martín Cañás, Héctor Omar Buschiazzo, Martín Alejandro Urtasun

Inequity in access to vaccines: the failure of the global response to the COVID-19 pandemic Open Access
Antonio Ugalde, Fernando Hellmann, Núria Homedes

1 - 17 of 17 items